Observer investigation shows drug company money flows through the NHS, raising questions about conflict of interest.
When the NHS celebrated its 75th anniversary last week, it prompted a fresh debate about a healthcare system on the brink of collapse.
Prof Philip Banfield, the chair of the council of the British Medical Association, warned the union’s annual meeting in Liverpool that every indicator in the NHS was “flashing red”. A chief executive at an acute NHS trust said they felt the health service was “locked in a death spiral”, with trusts struggling with staff and inadequate resources in the face of mounting pressure.
